Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Capital Employed (2021 - 2022)

Historic Return on Capital Employed for Atea Pharmaceuticals (AVIR) over the last 2 years, with Q3 2022 value amounting to 0.05%.

  • Atea Pharmaceuticals' Return on Capital Employed fell 200.0% to 0.05% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.05%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.18% for FY2021, which is N/A changed from last year.
  • Atea Pharmaceuticals' Return on Capital Employed amounted to 0.05% in Q3 2022, which was down 200.0% from 0.04% recorded in Q2 2022.
  • Atea Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.18% for Q4 2021, and its period low was 0.04% during Q2 2022.